City Of New York

The City of New York Department of Health and Mental Hygiene, doing business as Health Dept, acts as a federal grant recipient and federal contract prime for public health surveillance, disease prevention, and laboratory services delivered to civilian health and homeland security agencies. A U.S. local government entity and child division of the State of New York, Health Dept operates as a full-and-open competitor with no SBA set-aside posture, headquartered in Long Island City, New York.

Health Dept's federal footprint centers on infectious disease surveillance, prevention programming, and laboratory capacity. The recipient delivers cooperative agreements and grants to the Centers for Disease Control and Prevention (CDC) across HIV/AIDS surveillance, tuberculosis elimination, vaccine-preventable disease prevention, sexually transmitted infection surveillance, and epidemiology and laboratory capacity for emerging infectious diseases. Recent grants include a $2.613 million CDC cooperative agreement for the Medical Monitoring Project supporting HIV surveillance activities (CFDA 93.944, awarded September 2025, performance through September 2030); a $44.857 million HUD Housing Opportunities for Persons with AIDS (HOPWA) formula grant for permanent supportive housing and services to low-income individuals with HIV/AIDS (awarded September 2025, performance through September 2028); and a CDC cooperative agreement for strengthening vaccine-preventable disease prevention and response across immunization programs and outbreak response (awarded July 2025, performance through June 2030). Health Dept also holds a $3.683 million Food and Drug Administration definitive contract for Mammography Quality Standards Act (MQSA) implementation (awarded September 2022, performance through March 2028, located in Astoria, New York). Contract work includes annual $100,000 purchase orders with the Department of Homeland Security's Countering Weapons of Mass Destruction office for technical and management support to BioWatch laboratory operations (five consecutive awards from September 2022 through September 2026).

Customer concentration skews heavily to health and human services agencies. The CDC accounts for approximately 84 awards (42% of the 197 total awards tracked), while the Department of Homeland Security Countering Weapons of Mass Destruction office holds 10 awards. By potential value, the FDA anchors $11.6 million across five awards, and DHS CWMD carries $589 thousand across ten awards. Recent annual award volume has grown from five awards in 2022 to a peak of 18 in 2024, with six awards in 2026 year-to-date. Thirteen awards (combined potential value $3.8 million) face ultimate completion within the next twenty-four months and therefore carry recompete exposure.

Grant sub-award activity positions Health Dept as a pass-through recipient managing flows to nonprofit and academic partners. Named prime grantees receiving sub-awards include Public Health Solutions, The Trustees of Columbia University in the City of New York, Health Research Inc., the New York State Commission on National & Community Service, the Fund for Public Health in New York Inc., the Research Foundation of the City University of New York, Brown University, the New York State Office of Mental Health, Albert Einstein College of Medicine, and New York University. Sub-award work spans HIV treatment implementation (long-acting injectable antiretroviral therapy protocols with Columbia), mold remediation and asthma health outcomes research in public housing (Columbia), workforce development in clinical laboratory training (CDC), violent death reporting systems (Health Research Inc.), maternal mortality prevention (Health Research Inc.), and diabetes prevention programming tailored for Black and Latino men (Albert Einstein College of Medicine). Work is performed primarily in New York City across multiple boroughs with administrative oversight in Long Island City.